Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
The company plans to establish similar healthcare centres across universities, schools, and corporate campuses nationwide
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
